Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · ULTRALIFE CORP (ULBI)

Ultralife Q1 sales fall 6.5% to $47.4 million; operating result swings to loss

Negative Impact 4 of 5 earnings Written later

Ultralife reported first-quarter 2026 sales of $47.4 million, down 6.5% from $50.7 million a year earlier, and an operating loss of $0.2 million compared with operating income of $3.4 million. The company cited a power outage, lost production days at its Raynham, MA facility, and weak Communications Systems orders, and said its record backlog of $115.1 million gives it a basis to restore profitability in 2026.

Key points

  • Sales were $47.4 million versus $50.7 million; Communications Systems sales fell 25.7% to $3.3 million.
  • GAAP EPS was ($0.03) versus $0.11, and adjusted EBITDA was $3.2 million versus $5.4 million.
  • Operating result included one-time costs of $1.7 million; gross margin fell to 21.3% from 25.1%.
  • Backlog reached $115.1 million, up from $110.2 million at the end of 2025.

The filing

CompanyULTRALIFE CORP (ULBI)
Form8-K, current report
Filed with the SECMay 8, 2026, 7:30 AM ET
Accession number0001437749-26-015749

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 08, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.